Dengue Fever
📧 Sign up to get email alerts when something new happens for Dengue Fever.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia
Completed trial update on sylvatic transmission of Zika, dengue, and chikungunya viruses in Thailand and Cambodia, sponsored by NIAID, with …
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety of Takeda's tetravalent dengue vaccine candidate (TDV) in flavivirus-naïve and dengue…
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: Study of AT-752 in Patients With Dengue Infection [Phase 2]
Phase 2 study of AT-752 in dengue infection was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Dengue Tetravalent Vaccine (TDV) and recombinant 9-valent HPV vaccine (9vHPV) in parti…
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome [Phase 2]
Phase 2 clinical trial investigating whether vitamin D can prevent dengue haemorrhagic fever and dengue shock syndrome.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2022-10-14New vaccine to protect people in the EU and worldwide against dengue
EMA announces a new dengue vaccine to protect people in the EU and worldwide, representing a forthcoming or approved preventive option again…
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children [Phase 3]
Phase 3 results assess efficacy, safety, and immunogenicity of Takeda's tetravalent dengue vaccine (TDV) in healthy children, with results p…
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults [Phase 3]
Phase 3 trial update on immunogenicity and safety of the tetravalent dengue vaccine (TDV) at end of shelf life in healthy adults.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children [Phase 2]
Phase 2 trial reported safety and immunogenicity of Takeda's tetravalent dengue vaccine (TDV) in healthy children; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age [Phase 2]
A Phase 2 trial assessing immunogenicity and safety of different vaccination schedules for a tetravalent dengue vaccine in healthy adults an…
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue [Phase 3]
A Phase 3 trial update reports lot-to-lot consistency for the tetravalent dengue vaccine TDV in non-endemic settings; results posted in 2020…
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects [Phase 3]
Phase 3 trial update for a tetravalent dengue vaccine administered with Adacel either concurrently or sequentially in healthy subjects; stud…
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine [Phase 3]
Phase 3 trial update showing immunogenicity and safety of co-administering a tetravalent dengue vaccine with a Hepatitis A vaccine in health…
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of a tetravalent dengue vaccine given with or after Gardasil.
-
CLINICAL_TRIALS trial_result · 2020-04-27Clinical Trial Update: This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia [NA]
This clinical trial update describes a study on the burden of dengue fever illness among household members in selected communities in Latin …
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of a tetravalent dengue vaccine given with or after Cervarix, with completed statu…
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants [Phase 2]
Phase 2 trial update assessing safety and immunogenicity of different dosing schedules for Takeda's tetravalent dengue vaccine candidate TDV…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine [Phase 2]
Phase 2 trial update examining immunologic mechanisms and cross-neutralizing immunity after the CYD tetravalent dengue vaccine; trial comple…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore [Phase 2]
Phase 2 trial update evaluating safety and immunogenicity of two different serotype 2 potencies of Takeda's tetravalent dengue vaccine in ad…
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia [Phase 3]
Phase 3 trial update for a tetravalent dengue vaccine in healthy children showed completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore [Phase 2]
Phase 2 clinical trial update for Sanofi Pasteur's CYD Dengue Vaccine in healthy Singaporean subjects; study completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years [Phase 2]
Phase 2 trial update for the ChimeriVax tetravalent dengue vaccine in healthy children aged 2-11 years; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study
Long-term study of dengue vaccines in hospitalized Thai children completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Efficacy and Safety of Dengue Vaccine in Healthy Children [Phase 2]
Phase 2 trial results evaluate the efficacy and safety of a dengue vaccine in healthy children; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia [Phase 3]
Phase 3 trial of a tetravalent dengue vaccine in healthy adults completed; results posted in 2019.